Caris Life Sciences®, a molecular science and technology company, announced that The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has joined Caris’ Precision Oncology Alliance™. The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients.
OSUCCC – James is one of 51 National Cancer Institute (NCI)-designated comprehensive cancer centers and one of only a few centers funded by the NCI to conduct phase I, II and III clinical trials on novel anticancer drugs sponsored by the NCI. Read more.
